Clostridium Difficile infection after allogeneic hematopoietic stem cell transplant: Strain diversity and outcomes associated with NAP1/027

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 10, 2014, Pages 1626-1633

  Kamboj, Mini ^a,b   Xiao, Kun ^a   Kaltsas, Anna ^a,b   Huang, Yao Ting ^a   Sun, Janet ^a   Chung, Dick ^a   Wu, Saliangi ^c   Sheahan, Anna ^a   Sepkowitz, Kent ^a,b   Jakubowski, Ann A ^a,b   Papanicolaou, Genovefa ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Clostridium difficile infection; Immunocompromised host; NAP1 027 strain

Indexed keywords

CIPROFLOXACIN; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBACTERIAL ACTIVITY; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; RELAPSE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ALLOTRANSPLANTATION; CLOSTRIDIUM INFECTIONS; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; METRONIDAZOLE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84912522566     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.06.025     Document Type: Article

References (23)

1. Alonso C.D., Treadway S.B., Hanna D.B., et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2012, 54:1053-1063.
2. Chopra T., Chandrasekar P., Salimnia H., et al. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transplant 2011, 25:E82-E87.
3. Kamboj M., Son C., Cantu S., et al. Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Infect Control Hosp Epidemiol 2012, 33:1162-1165.
4. Loo V.G., Poirier L., Miller M.A., et al. Apredominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. NEngl J Med 2005, 353:2442-2449.
5. Samore M.H., DeGirolami P.C., Tlucko A., et al. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994, 18:181-187.
6. Willems L., Porcher R., Lafaurie M., et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2012, 18:1295-1301.
7. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
8. Valiquette L., Low D.E., Pepin J., McGeer A. Clostridium difficile infection in hospitals: a brewing storm. Can Med Assoc J 2004, 171:27-29.
9. Boutros M., Al-Shaibi M., Chan G., et al. Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation 2012, 93:1051-1057.
10. Mitu-Pretorian O.M., Forgacs B., Qumruddin A., et al. Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation. Transplant Proc 2010, 42:2631-2633.
11. Bobak D., Arfons L.M., Creger R.J., Lazarus H.M. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?. Bone Marrow Transplant 2008, 42:705-713.
12. Dubberke E.R., Reske K.A., Srivastava A., et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant 2010, 24:192-198.
13. Treatment of Clostridium difficile infection. Med Lett 2011, 53:1358.
14. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. Acomparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
15. Chakrabarti S., Lees A., Jones S.G., Milligan D.W. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant 2000, 26:871-876.
16. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997, 97:855-864.
17. Bidet P., Barbut F., Lalande V., et al. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 1999, 175:261-266.
18. Griffiths D., Fawley W., Kachrimanidou M., et al. Multilocus sequence typing of Clostridium difficile. JClin Microbiol 2010, 48:770-778.
19. Kinnebrew M.A., Jenq R.R., Lipuma L., et al. Clostridium difficile colonization and infection during allogeneic hematopoietic stem cell transplantation. PLoS One 2014, 9:e90158.
20. Jain T, Banavasi HVR, Urday-Cornejo V, et al. Prospective evaluation of toxigenic and non-toxigenic strains of Clostridium difficile colonization and infection among allogenic hematopoietic stem cell transplant recipients, 2010-2012. Presented at ID week, San Francisco, October 2-6, 2013, abstract number627.
21. Dallal R.M., Harbrecht B.G., Boujoukas A.J., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002, 235:363-372.
22. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
23. Longtin Y., Trottier S., Brochu G., et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013, 56:67-73.